‘Regenerative’ food labels are everywhere: Here’s why you may want to look twice :: WRAL.comOctober 17, 2026
General invIOs publishes positive clinical data on CBL-B-silenced autologous cell therapy APN401 in peer-reviewed journalBy Healthcare Propulsion StaffOctober 16, 20260 invIOs GmbH (“invIOs”), a privately held biotechnology company developing innovative cancer immunotherapies, today announced the publication of new clinical data…
